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High-throughput assays, such as RNA-seq, to detect differential abundance are widely used. Variable performance
across statistical tests, normalizations, and conditions leads to resource wastage and reduced sensitivity. EDDA
represents a first, general design tool for RNA-seq, Nanostring, and metagenomic analysis, that rationally selects
tests, predicts performance, and plans experiments to minimize resource wastage. Case studies highlight EDDA’s
ability to model single-cell RNA-seq, suggesting ways to reduce sequencing costs up to five-fold and improving
metagenomic biomarker detection through improved test selection. EDDA’s novel mode-based normalization for
detecting differential abundance improves robustness by 10% to 20% and precision by up to 140%.Background
The availability of high-throughput approaches to do
counting experiments (for example, by using DNA se-
quencing) has enabled scientists in diverse fields (espe-
cially in Biology) to simultaneously study a large set of
entities (for example, genes or species) and quantify
their relative abundance. These estimates are then com-
pared across replicates and experimental conditions to
identify entities whose abundance is significantly altered.
One of the most common scenarios for such experi-
ments is in study of gene expression levels, where se-
quencing (with protocols such as SAGE [1], PET [2],
and RNA-Seq [3]) and probe-based approaches [4] can
be used to obtain a digital estimate of transcript abun-
dance in order to identify genes whose expression is al-
tered across biological conditions (for example, cancer
versus normal [5]). Other popular settings where such
differential abundance analysis is performed include the
study of DNA-binding proteins and histone modifica-
tions (for example, using ChIP-Seq [6,7]), RNA-binding
proteins (for example, using RIP-Seq [8] and CLIP-Seq
[9]), and the profiling of microbial communities (using
16S rRNA amplicon [10] and shotgun sequencing [11]).* Correspondence: nagarajann@gis.a-star.edu.sg
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unless otherwise stated.Due to its generality, a range of software tools have
been developed to do differential abundance tests (DATs),
often with specific applications in mind, including popular
programs such as edgeR [12], DEseq [6], Cuffdiff [13,14],
Metastats [11], baySeq [15], and NOISeq [16]. The di-
gital nature of associated data has allowed for several
model-based approaches including the use of exact tests
(for example, Fisher’s Exact Test [11]), Poisson [17], and
Negative-Binomial [6,12] models as well as Bayesian [15]
and Non-parametric [16] methods. Recent comparative
evaluations of DATs in a few different application settings
(for example, for RNA-Seq [6,16,18-21] and Metage-
nomics [11]) have further suggested that there is notable
variability in their performance, though a consensus on
the right DATs to be used remains elusive. In addition, it
is not clear, which (if any) of the DATs are broadly applic-
able across experimental settings despite the generality of
the statistical models employed. The interaction between
modeling assumptions of a DAT and the application
setting, as defined by both experimental choices (for
example, number of sequencing reads to produce for
RNA-seq) as well as intrinsic experimental characteris-
tics (for example, number of genes in the organism of
interest), could be complex and not predictable a priori.
Correspondingly, only in very recent work, have experi-
mental design issues been discussed in a limited setting,
that is, using a t-test for RNA-seq analysis [22]. Also, as. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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several dimensions (Table 1), a systematic assessment of
DATs under all conditions is likely to be infeasible. As a
result, the choice of DAT as well as decisions related to
experimental design (for example, number of replicates
and amount of sequencing) are still guided by rules of
thumb and likely to be far from optimal.
In this study, we establish the strong and pervasive im-
pact of experimental design decisions on differential
abundance analysis, with implications for study design in
diverse disciplines. In particular, we identified data nor-
malization as a source of performance variability and de-
signed a robust alternative (mode normalization) that
uniformly improves over existing approaches. We then
propose a new paradigm for rational study design based
on the ability to model counting experiments in a
wide spectrum of applications (Figure 1). The resulting
general-purpose tool called EDDA (for ‘Experimental
Design in Differential Abundance analysis’), is the first
program to enable researchers to design experiments
for single-cell RNA-seq, NanoString assays, and Meta-
genomic sequencing, and we highlight its use through
case studies. EDDA provides researchers access to an
array of popular DATs through an intuitive online inter-
face [25] and answers questions such as ‘How much se-
quencing should I be doing?’, ‘Does the study adequately
capture biological variability?’, and ‘Which test should I
use to sensitively detect differential abundance in my
application setting?’. To provide full access to its func-
tionality, EDDA is also available as a user-friendly R
package (on SourceForge [26] and Bioconductor [27]),
and is easily extendable to new DATs and simulation
models. The R package as well as the website provide
different metrics to assess the performance of DATsTable 1 Experimental conditions affecting differential abunda
Abbr. Description
Experimental choices Number of replicates NR Number of t
replicates fo
in the test




Entity count EC Number of e
experiment
Sample variability SV Variability ac
Abundance profile AP Relative abu
first group
Perturbation profile PDA, FC Perturbation
the first grou
the second g
Test settings Biases in data generation Deviations f
due to biase
experimenta
Differential abundance test DAT See Table 2including the area under curve (AUC) of the receiver
operating characteristic (ROC) curve, precision-recall
curves, and actual versus estimated false discovery rate
(FDR).
Results
In the following, we present and emphasize the under-
appreciated impact of various experimental conditions
(grouped into two categories: experimental choices and
experimental characteristics, see Table 1) and various
popular DATs (see Table 2) on the ability to detect dif-
ferential abundance. Our results highlight the import-
ance of careful experimental design and the interplay
between experimental conditions and DATs in dictating
the success of such experiments. We first establish that
the impact of experimental choices on performance can
be significant and in the next section explore their inter-
action with various experimental characteristics. The re-
sults presented here are based on synthetic datasets to
allow controlled experiments and exploration of a wide-
range of parameters, with no emphasis on a particular
application. Note that these comparisons are not meant
to serve as a benchmark (more sophisticated compari-
sons and benchmarks can be found in other studies
[6,11,16,18-21,28]) but instead to motivate the need for
and the specific design decisions in EDDA. In the fol-
lowing section, we discuss the validity of the modeling
assumptions and parameter ranges that we investigated
and used to guide the design of EDDA. We conclude by
showcasing EDDA’s application in various settings. For
ease of reference, a schematic overview of the simulation
model in EDDA (Figure 1a) and a flowchart of how it
can be used (Figure 1b) is provided in Figure 1 with de-
tailed descriptions in the Methods section.nce tests (DATs)
Notes
echnical or non-technical
r the two groups compared
For simplicity, in many cases, we assume
NR to be the same in both groups
ata-points generated in the
periment
For example, reads generated in an
RNA-seq experiment
ntities in the counting For example, number of genes in an
RNA-seq experiment
ross replicates (see Methods) For example, biological variability in
RNA-seq datasets
ndance of the entities in the Typically follows a power-law distribution
s to the abundance profile of
p to obtain the profile for
roup (see Methods)
Used to generate the differentially
abundant entities (PDA = Percentage of
entities, FC = fold-change distribution)
rom multinomial sampling
s inherent in the
l protocol
These are often corrected for in a
preprocessing step, for example,
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Entity  Fold-Change   p-Value   FDR
  A             153            3e-20     3e-16
  B               96            6e-18     6e-14
  C               64            5e-16     5e-12














         testing with EDDA 
Figure 1 A schematic overview of EDDA and its usage. (a) Overview of the simulate-and-test approach used in EDDA involving four key steps
(see Methods for details). The figure also indicates the various parameters studied here, that impact the ability to predict differentially abundant
entities (also see Table 1), in red and green text. (b) A flowchart describing how EDDA can be used to optimize design and performance in a
counting experiment. EDDA functionality is depicted in green boxes and rhombi indicate decision nodes.
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While the availability of high-throughput technologies
(such as massively parallel DNA sequencing) to do count-
ing experiments has significantly increased the resolution
of such experiments, the cost of the experiment is oftenTable 2 Description of various software packages for conduct
Name Statistical testing Nor
edgeR [12] Negative Binomial Model, Conditional Maximum
Likelihood to estimate parameters, Exact Test
TMM
DESeq [6] Negative Binomial Model, local regression to
estimate parameters, Exact Test
Nor
baySeq [15] Negative Binomial Model, empirical Bayes to
estimate parameters
RPM
NOISeq [16] Non-parametric approach RPM
Cuffdiff [14] t-test RPM
Metastats [11] Non-parametric t-test, Fisher’s Exact Test for
small counts
RPM
RPKM: Normalization by read count and gene length (RNA-seq) [3], RPM: Normaliza
UQN: Upper Quartile Normalization [20].still an important factor and the number of replicates and
data-points that can be afforded may be less than optimal.
Furthermore, in many settings the number of replicates or
the number of data-points possible may be constrained
due to technological limitations or uniqueness of samplesing differential abundance tests
malization approach Target application areas
, UQN SAGE [1], MPSS [29], PMAGE [30], miRAGE
[31] and SACO [32] among others
malization by median RNA-seq [3], HITS-CLIP [9] and ChIP-seq
[33] among others
, TMM DNA-seq, RNA-seq [3] and SAGE [1]
among others
, RPKM, UQN ChIP-seq [33] and RNA-seq [3] among others
, RPKM, UQN RNA-seq [3]
Metagenomics
tion by read count (RNA-seq), TMM: Trimmed Mean of M values [34],
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understand and exploit the trade-off between the number
of replicates and data-points needed (for example, by
doing deeper RNA-seq for a few biological replicates) for
such analysis. In the following, we investigate these di-
mensions individually and in conjunction. For consistency
and ease of comparison, we typically use AUC as the
metric for performance (with precision-recall curves being
provided in the supplement) to highlight variability across
conditions. In practical applications, other metrics such as
the true-positive rate and actual FDR while controlling for
FDR (methods such as NOISeq would need alternative
thresholds) may be more appropriate and are also sup-
ported by EDDA.
Number of replicates
The performance of DATs (measured in terms of AUC)
as a function of the number of replicates (NR) in the
study is highly non-linear, with significant improvements
obtainable until a saturation point (indicated by a larger
marker size; Figure 2a). The saturation point is likely to be































Figure 2 Performance of DATs as a function of experimental choices.
of the number of data-points with (b) one replicate, (c) two replicates, and
the average per entity. Points with large markers indicate the saturation po
Results reported are based on an average over 10 simulations with the foll
ND =1,000 per entity, AP = BP, SM = NB, and SV =0.85 (see Table 1 and Mein an experiment. However, clear differences are also seen
across DATs as seen in Figure 2a, where edgeR and DESeq
achieved AUC greater than 0.95 with five replicates, while
baySeq required eight replicates and has substantially
lower AUC with one replicate. While all DATs seem to
converge toward optimal performance (AUC =1) in this
setting, the rate of convergence varies markedly (for ex-
ample, note the curve for Cuffdiff). Note that the relative
performance of DATs is influenced by the experimental
setting, especially in conditions where the number of rep-
licates available is small (as is typically the case), and thus
the choice of DAT is strongly dependent on the desired
precision/recall trade-off (Additional file 1: Figure S1).
Number of data-points
The number of data-points (ND) generated in an appli-
cation setting is often set to be the maximum possible
given the resources available. However, this may lead to
misallocation of resources as suggested by Figure 2b, c,
and d. In this setting, increasing the number of data-points
continues to improve AUC over a wide range of values (for
































(a) AUC as a function of the number of replicates. AUC as a function
(d) five replicates. Note that the number of data-points reported is
int where the AUC is within 5% of the maximum observed AUC.
owing parameters, EC =1,000, PDA =26%, FC = Uniform (3, 5),
thods for key to abbreviations used here).
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DATs (baySeq), performance decreases with increase in
ND - a feature that is not a priori evident from its specifi-
cation (Figure 2b). However, with more replicates, much
fewer data-points are needed to obtain high AUC values,
suggesting that this is a better trade-off in this setting
(Figure 2c, d; not necessarily the case in other settings,
for example, when the number of replicates is already
high or intrinsic variability across replicates is low).
Note that if the number of data-points is limited by the
application, then there is considerable variability in per-
formance across DATs (Additional file 1: Figure S2) and
some DATs may have consistently lower AUCs (Cuffdiff
and Metastats, in this setting) with high ND as well.
Thus, to meet experimental objectives, especially when
high precision is desired, informed decisions on sta-
tistical test and number of replicates to employ are nee-
ded (as facilitated by experimental design tools such as
EDDA).
Interaction of experimental characteristics and choices
It is important to note that experimental choices alone
do not dictate the ability to detect signals of differential
abundance and as we show here, the intrinsic character-
istics of the experiment are also an important variable
that need to be taken into account. This excludes the
possibility of pre-computing recommendations for ex-
perimental choices and DATs to use in various applica-
tions and emphasizes the need for a general-purpose
experimental design tool such as EDDA.
Entity count
Intuitively, the impact of entity count (EC) being profiled
is expected to be minimal and the a priori assumption is
that scaling the number of data-points as a function of the
number of entities should lead to comparable perform-
ance. Our results suggest that this is not quite true. As
seen in Figure 3a, when the number of entities is low,
there is not only greater variability in performance, but
average AUC is also lower. Some statistical tests seem to
be less appropriate when the number of entities is low (for
example, Cuffdiff), while others exhibited greater robust-
ness (edgeR and DESeq, followed by baySeq).
Sample variability
The intrinsic variability seen across replicates in an ap-
plication setting dictates the trade-off between the num-
ber of data-points and replicates needed in complex
ways as shown in Figure 3b. While the specific patterns
will depend on the application, even for a setting with
large effect sizes as shown here, the specific trade-offs
chosen by the various DATs vary (more sequencing for
DESeq vs. more replicates for Cuffdiff ) and the cost-
effectiveness of a method (= NR ×ND needed) can switchwith sample variability (SV) (for example, Cuffdiff goes
from being the least to the most cost-effective when sam-
ple variability increases; Figure 3b).
Abundance profile
The relative abundance of entities is often seen to follow
a power law distribution (Additional file 1: Figure S3),
but the precise shape can vary and together with the
number of data-points generated, impact overall per-
formance for an application. In particular, testing differ-
ential abundance for rare entities (with low relative
abundance) can be difficult and could explain the variabil-
ity in performance seen in Figure 3c. While all methods
have lower AUC for a rare-entity-enriched profile from
Wu et al. [35] (Additional file 1: Figure S3), some methods
seem to be more robust (for example, baySeq) or tuned to
detect rare entities (for example, Metastats), while others
experience a larger relative drop in performance (for ex-
ample, Cuffdiff or NOISeq), suggesting that DAT choices
need to take abundance profiles (APs) into account.
Perturbation profile
The effect of specific profiles of differential abundance
on prediction performance is likely to be the least pre-
dictable from first principles and this was also seen in
our experiments (Figure 4). Altering the fraction of dif-
ferentially abundant entities alone could reorder the per-
formance of various statistical tests, as seen in Figure 4a
and b, where baySeq went from being the worst per-
former to the best performer. Furthermore, switching
the distribution of fold-changes was also seen to affect
results as seen in Figure 4b and c, with NOISeq now be-
coming the best performing DAT. Other parameters
such as the abundance profile also combine with the
perturbation profile to influence relative performance as
seen in Figure 4b and d, where DEseq went from being
one of the best to being the worst performer. Overall, no
single DAT was found to outperform others (Additional
file 1: Figure S4), highlighting that specific experimental
characteristics and choices need to be taken into account
while choosing an appropriate DAT.
Modeling assumptions and normalization
In the absence of variability across replicates (that is,
technical or biological variability) and experimental bia-
ses, counting experiments of the sort studied here are
naturally modeled as samples from a Multinomial distri-
bution (we refer to this as the Multinomial model in
EDDA). To simulate technical and intrinsic variability, a
common approach has been to model the relative abun-
dance of each entity across replicates using the Negative
Binomial distribution [15,36]. In fact, in many studies
this is the model from which counts are simulated for
each entity [15,37], independent of those for other entities
Figure 3 Performance of DATs as a function of experimental characteristics. (a) AUC as a function of entity count (small =100, medium =
1,000, large =30,000). Simulations were done with the same parameters as in Figure 2a, except with ND =100 per entity, AP = HBR, SM = Full, and
FC = Log-normal [1,2]. (b) AUC as a function of SV (and NR, ND per entity), where low, medium, and high were set to SV =0.05, 0.5, and 0.85,
respectively. Note that the plotted point shows the smallest NR and ND values (small NR was given priority in the case of ties) that achieved an
AUC target of 0.95. Synthetic data were generated with EC =1,000, PDA =10%, FC = Uniform (8, 8), AP = BP, and SM = NB. (c) AUC as a function of
abundance profile. Simulations were done with the same parameters as in Figure 2a and with NR =5 and ND =500 per entity. The inset shows
the fraction of rare entities (mean count <10) in each abundance profile. Results reported are based on an average over 10 simulations and error
bars in (a) and (c) represent one standard deviation.
Luo et al. Genome Biology 2014, 15:527 Page 6 of 17
http://genomebiology.com/2014/15/12/527(we refer to this as the Negative Binomial model), and
bypassing the joint simulation of counts from a Multi-
nomial distribution (referred to here as the Full model).
For most current high-throughput experiments, as bio-
logical variation is significant, the Full Model that incor-
porates multinomial sampling of counts while modeling
sample-to-sample variability as a negative binomial dis-
tribution is appropriate. EDDA also includes an outlier
simulation model that allows users to simulate more rea-
listic datasets for some settings (for example, RNA-seq
[28]; see Methods). In practice, both the Full and the
Negative Binomial model elicit similar performance for
most experimental settings and most DATs. However,
for a few DATs (baySeq, NOISeq, and Cuffdiff) we ob-
served deterioration in performance on the Full model
when compared to a similar experiment using the NegativeBinomial model (Additional file 1: Figure S5) suggesting
that the Full model is a better measure of performance
of a DAT.
By analyzing several published and in-house datasets
we established that, in general, for bulk transcriptome
sequencing (confirming earlier reports [15,36]), Nano-
string assays and Shotgun Metagenomic sequencing (not
shown in prior work), variability in replicates can be ad-
equately modeled using the negative binomial distribution
(Additional file 1: Figure S6). An exception to this rule
was, however, seen in single-cell RNA-seq experiments in
accordance with observations of unusually high cell-to-
cell variability in recent reports [38,39] (Additional file 1:
Figure S6c, d). For cases where an appropriate model
for variability across replicates is not available (as in the
single-cell case), we developed a Model-Free approach,





































































↑ ↓PDA:5% 5% ↑ ↓PDA:50% 25%
↑ ↓PDA:50% 25% +FC:logN(2,1) ↑ ↓PDA:50% 25% +AP:HBR
Figure 4 ROC plots under various perturbation profiles. Statistical tests in the legend are listed from best to worst (in terms of AUC values)
for each setting. Note the striking reordering of test performance across subfigures with slight changes in experimental conditions. Simulations in
EDDA were done with (a) PDA =10%, (b) PDA = (50% UP, 25% DOWN), (c) PDA = (50% UP, 25% DOWN), FC = Log-normal (2, 1), (d) PDA = (50%
UP, 25% DOWN), AP = HBR. Unless stated otherwise, common parameters include NR =3, EC =1,000, FC = Uniform(3, 7), ND =500 per entity,
AP = BP, SM = Full, and SV =0.5.
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needed) of existing datasets to provide simulated datasets
that match sample-to-sample variability in real datasets
better (with the drawback that it relies on the availability
of a dataset with many replicates; see Methods).
To evaluate the data generation models used in this
study (either model-based or model-free), as well as es-
tablish their suitability for the design of EDDA, we first
investigated distributional properties of real and simu-
lated datasets (Additional file 1: Figure S7). The results
here indicate that while overall both simulation approa-
ches (where applicable) provide good approximations
and capture the general trend, the Model-Free approach
more closely mimics true sample variability (Additional
file 1: Figure S7). We next tested the suitability of an ap-
proach where simulated datasets are generated to mimic
an existing pilot dataset and employed to measure trends
in performance. Our results confirmed that simulateddata generated by our simulation models enable reliable
measurement of true performance for DATs (relative-
error in AUC <6%) and monitoring of trends as a function
of experimental choices and characteristics (Additional
file 1: Figure S8). In addition, experimental recommen-
dations from EDDA simulations were also found to
match DAT recommendations based on benchmarking
on real datasets [40] (Additional file 1: Figure S9), sug-
gesting that EDDA can help avoid this step and still reli-
ably guide experimental design.
In some experimental settings, variability in replicates
can be extremely low and directly simulating from the
Multinomial distribution (a special case of the Full model
that we refer to as the Multinomial model; see Methods)
is sufficient. In principal, with enough data-points, sta-
tistical testing under the Multinomial model should be
straightforward and we expect various DATs to perform
well. The few exceptions that we noted, suggest that aspects
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may play a role in their reduced performance (Additional
file 1: Figure S5).
An investigation of different normalization approaches
(Table 2) under the various experimental conditions ex-
plored in this study suggests that their robustness can vary
significantly as a function of the experimental setting. In
particular, we observed a few settings under which many
of the existing approaches performed sub-optimally
(Figure 5a) and to address this we designed a new
method (mode normalization) that analyzes the distri-
bution of un-normalized fold-changes of entities using
mode statistics to select a suitable normalization fac-
tor (see Methods and Additional file 1: Figure S10). WeFigure 5 Comparison of different data normalization approaches. (a)
normalization by the sum of counts for all non-differentially-abundant entit
Upper-quartile Normalization (UQN) improved over the Default normalizati
did not we mark its performance with a solid line. Mode normalization alw
normalization for the DAT (improvement shown by the solid box). The par
DOWN), AP =Wu et al.; B: PDA = (35% UP, 15% DOWN); C: PDA = (40% DOW
otherwise, common parameters include NR =3, EC =1,000, FC = Log-norma
Comparison on real datasets, highlighting the robustness of mode normali
of the top 500 differentially abundant genes (sorted by P value using edge
those where one of the libraries is down-sampled (5% or 10% of original si
one standard deviation.compared mode normalization to the default normaliza-
tion and a popular alternate (Upper-quartile Normaliza-
tion), for each DAT and across all the conditions tested
here, to find that the use of mode normalization uniformly
improved performance (on average, AUC by 9% and preci-
sion by 14% at 5% FDR). Also, in cases where the perform-
ance of a few DATs dipped under the Multinomial model,
mode normalization was able to rescue the AUC values
(Additional file 1: Figure S5d). In addition, we identified
several examples where mode normalization significantly
improved AUC values for all the DATs tested (improving
precision to detect differential abundance by up to 140%
at 5% FDR), highlighting that proper data normalization is
a key step in attaining experimental goals (Figure 5a). AsOn simulated benchmark datasets using EDDA. Note that we used
ies (non-DA) as a measure of ideal performance here. In general,
on (improvement shown by the checked box) but for cases where it
ays improved over the performance from UQN and the Default
ameters for the various experiments include for A: PDA = (26% UP, 10%
N), SM =Mutinomial; and D: the same as in Figure 4b. Unless stated
l (1.5, 1), ND =500 per entity, AP = HBR, SM = Full, and SV =0.5. (b)
zation. Shown here is the overlap fraction (used to measure robustness)
R) in comparisons involving both the original full-size libraries versus
ze). Barplots show the average of five runs and error bars represent
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default normalization of a DAT or a popular alternate
(Upper-quartile Normalization) lead to reduced perform-
ance while calling differentially abundant entities, while
mode normalization consistently achieves optimal per-
formance across DATs. Note that no normalization can be
expected to work under all conditions and simulated data-
sets generated by EDDA can also be valuable to compare
and choose among alternative normalization techniques.
To further evaluate normalization methods on real
datasets, we studied the consistency of differential abun-
dance predictions (against predictions on the full data-
set) upon down-sampling of data-points, using three
deeply-sequenced RNA-seq datasets [40] (Figure 5b).
These results highlight the robustness of mode normali-
zation versus other popular approaches (UQN and TMM;
Table 2). Mode normalization was found to improve ro-
bustness by 10% to 20% across datasets and was the least
affected by imbalances in sequencing depth across condi-
tions (Figure 5b).
Applications of EDDA and mode normalization
The observed variability in the performance of DATs
across experimental characteristics and choices, and
the demonstration that data from many kinds of high-
throughput experiments can be adequately modelled in
silico, motivated the use of a simulate-and-test paradigm
in EDDA to guide experimental design (see Figure 1a
and Methods). EDDA allows users fine-scale control of
all the variables discussed here (summarized in Table 1),
but also provides the option to directly learn experi-
mental parameters (and models for the model-free ap-
proach) from pilot or publicly-available datasets. Some
of the commonly expected modes of usage for EDDA
are discussed in the Methods section ‘EDDA modules’
and illustrated in Figure 1b. Furthermore, to showcase
the use of EDDA and mode normalization, we present
results from EDDA analysis of several recently gener-
ated datasets in three different experimental settings,
each highlighting a different aspect of the utility of the
package in a practical scenario.
For the first case study, we analyzed data from a re-
cent single-cell RNA-seq study of circulating tumor
cells (CTCs) from melanoma patients [41]. The authors
generated on average 1,000 data-points per entity (>20
million reads) and used a one-way ANOVA test (equiva-
lent to a t-test) to identify differentially abundant genes
between CTCs and primary melanocytes. We reanalyzed
the data using EDDA to simulate synthetic datasets that
mimicked real data (with the Model-Free approach and
a 96-cell dataset generated as a resource for this study)
and used them to test a panel of DATs (see Methods).
The availability of new micro-fluidics based systems to
automate single-cell omics has highlighted the cost ofsequencing as the major bottleneck in studying a large
number of cells. Strikingly, EDDA analysis revealed that
this study could have been conducted with one-fifth of
the sequencing that was done (by reducing sequencing
depth to one-tenth and doubling the number of repli-
cates) without affecting performance in terms of iden-
tifying differentially abundant genes (Figure 6a). This
was, however, only possible if the appropriate DAT was
used (edgeR and BaySeq, in this case), with the choice
of DAT playing a more significant role than the amount
of sequencing done. Using BaySeq with on average 100
reads per gene (that is, 2 million reads per cell as op-
posed to the 20 million reads used in this study) and in-
creasing the number of replicates from five to 50 (and
thus maintaining sequencing cost) would be expected to
boost AUC from 0.86 (and 0.75 using the t-test) to 0.96
and sensitivity from 57% to 72% at 5% FDR, in this study
(Figure 6a). Note that while practical considerations
could limit the number of CTCs that can be captured
and studied, this should not be an issue for other cell
types in this study.
In the second case study, we analyzed data from an in-
house project (manuscript in preparation) for the de-
velopment of prognostic and predictive gene signatures
in breast cancer on the NanoString nCounter platform
(NanoString, WA, USA). The NanoString platform al-
lows for the digital measurement of gene expression, si-
milar to RNA-seq, but is typically used to profile a small,
selected set of genes in a large number of samples (107
genes and 306 samples in this study), making data nor-
malization a critical step for robust analysis. Using EDDA,
we explored the impact of a range of normalization ap-
proaches, including the one recommended in the Nano-
String data analysis guide (NanoString, WA, USA). As
shown in Figure 6b, the coefficient of variation (COV) of a
panel of six housekeeping genes (ACTG1, ACTB, EIF4G2,
GAPDH, RPLP0, and UBE2D4) is significantly lower, as
expected, when the data are properly normalized and, in
particular, this is the case when using mode normalization
which produces the lowest average COV across all the
methods tested. We then investigated the effect of nor-
malization on the power to discriminate between ER po-
sitive and negative breast cancers using a panel of eight
known ER signature genes [43]. Not surprisingly, the abil-
ity to distinguish ER positive and negative breast cancers
improves significantly with proper normalization with
mode normalization providing the largest F-score
(see Methods) among all the approaches tested (Figure 6c).
In our third case study, we critically assessed the ana-
lysis done in a recent Metagenomic study that looked
into the association of markers in gut microflora with
type 2 diabetes in Chinese patients [42]. Due to the
complexity of the microbial community in the gut, the
authors reported that they were able to assemble more
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Figure 6 Case studies of EDDA usage. (a) Predicted performance of DATs as a function of replicates (NR) and sequencing depth (ND) for a
single cell RNA-seq experiment (Ramskold et al. [41]). Note that the vertical black dashed line indicates design choices in the original study.
(b) Coefficient of variation for a panel of housekeeping genes from a NanoString experiment under different normalization approaches. (c)
Separability of ER positive and negative samples under different normalization approaches. (d) Predicted performance of DATs as a function of
replicates (NR) and sequencing depth (ND) for a Metagenomics experiment (Qin et al. [42]). Note that the vertical black and red dashed lines
indicate design choices in the original study and using one-fifth of the original amount of sequencing.
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since on average approximately 20 million paired-end
reads were generated per sample, the sequencing done
here is expected to provide shallow coverage of the gene
set, on average. The study involved a large number of
cases (71) and controls (74) and the Wilcoxon test was
used to identify differentially abundant genes in a case-
control comparison. Another batch of 100 cases and
controls was then used to validate biomarkers identified
from the first batch. We used EDDA to generate virtual
microbiome profiles and assessed the performance of
the Wilcoxon test in this setting, in addition to the de-
fault panel of DATs (Table 2). EDDA analysis revealed
that the Wilcoxon test was likely to have been too con-
servative in this setting and could have been improved
upon using DATs like Metastats, which was designed forMetagenomic data and edgeR, which is commonly used
for RNA-seq analysis (Figure 6d). In addition, while in-
creased coverage is likely to improve the ability to detect
true differences in the microbiome, the gains are ex-
pected to be relatively modest (for edgeR, approximatley
1% increase in AUC with 10-fold increase in sequencing;
Figure 6d). Correspondingly, despite the shallow cover-
age employed in this study, it is likely to have captured a
significant fraction of the biomarkers that could have
been determined with more sequencing. In contrast, in-
creasing the number of replicates is likely to have mark-
edly improved the ability to detect true differences in
the microbiome, (with edgeR, approximately 7% increase
in AUC by doubling the number of replicates Figure 6d).
Keeping sequencing cost fixed and using 300 replicates
and five reads per gene is thus expected to boost AUC
Luo et al. Genome Biology 2014, 15:527 Page 11 of 17
http://genomebiology.com/2014/15/12/527from 0.73 (using the Wilcoxon test) in the study to 0.97
(using edgeR; Figure 6d) and sensitivity from 32% to
86% at 5% FDR.
Based on this, we reanalyzed cases and controls from
the first batch in this study to identify an additional
37,664 differentially abundant genes (17% increase) using
edgeR, of which a greater fraction (27% increase over
the original study) were also validated in the second
batch of samples (Additional file 1: Table S2). The newly
identified genes highlighted previously missing aspects
of the role of the microbiome in Type 2 diabetes in-
cluding the identification of 24 additional gene families
enriched in differentially abundant genes (Additional
file 1: Table S3). In particular, this analysis detected two
bacterial genes identified as multiple sugar transport
system substrate-binding proteins as being abundant in
cases vs. controls (Additional file 1: Figure S11), as well as
the enrichment of two new families for multiple sugar
transport system permease proteins (K02025 and K02026).
Strikingly, the newly detected genes also enabled construc-
tion of an improved microbiome-based predictive model
for Type 2 diabetes (AUC of 0.96 vs. 0.81 in the original
study; see Methods and Additional file 1: Figure S11),
based on the selection of 50 marker genes (see Methods
and Additional file 1: Table S4), highlighting the disease-
relevance for the additional biomarkers that we detect and
that improved differential abundance analysis based on in-
formed choices using EDDA can significantly impact major
conclusions from a study.
Discussion and Conclusions
The case studies highlighted in the previous section are
not unique in any way and point to a general trend in
current design of high-throughput experiments, where
commonly used rules of thumb lead to suboptimal designs
and poor utilization of precious experimental resources.
Considering that the market for sequencing based experi-
ments alone is currently in the billions of dollars, savings
in research budgets worldwide would be substantial with
even a modest 10% improvement in study design. On the
other end, with a fixed budget, optimizing study design
can ensure that key insights are not missed. In particular,
in many scenarios where either (a) effect sizes are small
and fold-changes are marginal or (b) large effects on a few
entities mask subtle effects on other entities or (c) the
goal is to understand coordinated processes such as cel-
lular pathways through enrichment analysis [44], loss in
sensitivity or precision due to unguided experimental
choices can be detrimental to the study. The use of a
personalized-benchmarking tool such as EDDA pro-
vides a measure of insurance against this.
With the recent, dramatic expansion in the number of
high-throughput applications (largely based on DNA se-
quencing) as well as end-users (often non-statisticians),differential abundance testing is now frequently done by
non-experts in settings different from the original
benchmarks for a method. This can make it difficult to
determine if a particular analysis was appropriate or lead
to incorrect results. One possible approach that could
account for this is to use multiple DATs to get a consen-
sus set (also available as an option on the EDDA web-
server) but this can result in overly conservative predic-
tions. For example, in a recent analysis of RNA-seq data
from two temporally-separated mouse brain samples
using edgeR and DESeq (with default parameters), we
found that the intersection of differentially expressed
genes (at 10% FDR) contained less than 10% of the union.
Breakdown of the results showed that while edgeR was
primarily reporting upregulated genes (998 out of 1189),
DESeq was largely reporting downregulated genes (875
out of 878), with no indication as to which analysis was
more appropriate. EDDA simulations and analysis were
then used to clarify that results from edgeR were more re-
liable here (FPR of 3.8% vs. 9.2% at 10% FDR) and could
be improved further using mode-normalization (FPR of
1.5%). Furthermore, the bias towards detecting up- or
downregulated genes was intrinsic to the tests here (not
affected by normalization as we originally suspected) and
hence reporting the union of results was more appropri-
ate. Examples such as this are not uncommon in the ana-
lysis of high-throughput datasets and experimental design
tools such as EDDA can help provide informed answers to
researchers.
We hope the results in this study serve to further
highlight the still under-appreciated importance of pro-
per normalization for differential abundance analysis
with high-throughput datasets [20,45,46]. Normalization
based on mode statistics provides an intuitive alternative
to existing approaches, exhibiting greater robustness to
experimental conditions in general, >20% improved AUC
performance in some conditions, as well as the ability to
detect cases where proper normalization may not be
feasible.
EDDA was designed to provide an easy-to-use and
general-purpose platform for experimental design in the
context of differential abundance analysis. To our know-
ledge, it is the first method that allows users to plan
single-cell RNA-seq, Nanostring assays and Metagenomic
sequencing experiments (as well as other high-throughput
counting experiments, for example, ChIP-seq), where the
larger number of samples involved could lead to import-
ant experimental trade-offs. The combination of model-
based and model-free simulations in EDDA allows for
greater flexibility and, in particular, we provide evidence
that the commonly used Negative Binomial model may
not be appropriate for single-cell RNA-seq, but a model-
free approach (leveraging on a 96-cell dataset generated in
this study) is better suited. Model-free simulations using
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tests and clustering techniques for single-cell RNA-seq.
Note that a common assumption in EDDA and most stat-
istical testing packages is that deviations from the multi-
nomial model due to experimental biases can be corrected
for and hence these issues were ignored in this study
[14,23]. However, we include an outlier simulation model
that allows users to investigate the impact of potential out-
liers in their data on various DATs that are more or less
tuned to handle them [28].
EDDA was developed for count-based analysis, where
its model-based simulations assume that counts from
different entities are not correlated. In some applica-
tions, such as transcript-level quantification using short-
read RNA-sequencing, this assumption may not be valid
due to technical reasons (for example, ambiguity in read
mapping). Currently, this limitation can only be circum-
vented by using the model-free approach in EDDA,
based on sample data where entities are correlated (for ex-
ample, by using transcript-level mapping for RNA-seq).
Further work is needed to develop appropriate model-
based approaches that adequately simulate technical ar-
tefacts in count data and will necessarily have to be
application-specific. Note that gene and exon-level quanti-
fication are common applications of RNA-seq (as indi-
cated by the majority of DATs being designed for this) and
should benefit from model-based analysis in EDDA. Fur-
thermore, with improvements in sequencing read length
as well as adoption of third-generation sequencing tech-
nologies, issues related to ambiguous read assignment are
likely to affect a small fraction of reads. The use of EDDA’s
model-based analysis is thus expected to become increas-
ingly feasible in this burgeoning application area.
Recently, McMurdie et al. demonstrated the applic-
ability of normalization/detection methods designed for
RNA-seq data (edgeR/DESeq) for analyzing metage-
nomic count data [47]. This study supports the under-
lying basis of our work that methods for normalization
and differential abundance testing should be broadly ap-
plicable beyond the domains for which they were origin-
ally proposed. Cross-fertilization of best practices from
various application areas can improve the analysis of
high-throughput count data and we hope that general
platforms such as EDDA accelerate this process.
The basis for EDDA is a simple simulate-and-test pa-
radigm as the diversity of statistical tests precludes more
sophisticated approaches (for example, deriving closed-
form or numerical bounds on expected performance).
Given the simplicity of this approach, it is even more
surprising that the field has until now relied on rules of
thumb. In light of this, the main contribution of this
work should be seen as the demonstration that signifi-
cant variability can be observed across all experimental
dimensions and, therefore, lack of experimental designtailored to a particular application setting can lead to
substantial wastage of resources and/or loss of detec-
tion power. We hope that the availability of EDDA
through an intuitive, easy-to-use, point-and-click web-
based interface will thus encourage a wide-spectrum
of researchers to employ experimental design in their
studies.Methods
Single-cell library preparation and sequencing
ATCC® CCL-243™ cells (that is, K562 cells) were thawed
and maintained following vendor’s instructions using
IMDM medium (ATCC® 30-2005™) supplemented with
10% FBS (GIBCO® 16000-077™). The cells were fed every
2 to 3 days by dilution and maintained between 2 × 10
[5] and 1 × 10 [6] cells/mL in 10 to 15 mL cultures kept
in T25 flasks placed horizontally in an incubator set at
37°C and 5% CO2. Cells were slowly frozen 2 days after
feeding at a concentration of 4 million cells per mL in
100 μL aliquots of complete medium supplemented with
5% DMSO (ATCC® 4X). The cryo-vials containing the
frozen aliquots were kept in the vapor phase of liquid ni-
trogen until ready to use. On the day of the C1™ experi-
ment, a 900 μL aliquot of frozen complete medium was
thawed and brought to room temperature. The cryo-vial
was retrieved from the cryo-storage unit and placed in
direct contact with dry ice until the last minute. As soon
as the cryo-vial was taken out of dry ice, the cells were
thawed as quickly as possible at a temperature close to
37°C (in about 30 s).
The room temperature complete medium was slowly
added to the thawed cells directly in the cryo-tube and
mixed by pipetting four to five times with a 1,000 μL
pipette tip. This cell suspension was mixed with C1™ cell
suspension reagent at the recommended ratio of 3:2 im-
mediately before loading 5 μL of this final mix on the
C1™ IFC. The C1 Single-Cell Auto Prep System (Fluidigm)
was used to capture individual cells and to perform cell
lysis and cDNA amplification following the chip manufac-
turer’s protocol for single-cell mRNA-seq (PN 100-5950).
Briefly, chemistry provided by the SMARTer Ultra Low
RNA Kit (Clontech) was used for reverse transcription
and subsequent amplification of polyadenylated tran-
scripts using the C1™ script 1772×/1773×. After harvest
of the amplified cDNA from the chip, 96-way bar-coded
Illumina sequencing libraries were prepared by tagmen-
tation with the Nextera XT kit (Illumina) following the
manufacturer’s protocol with modifications stated in
Fluidigm’s PN 100-5950 protocol. The 96 pooled librar-
ies were 51-base single-end sequenced over three lanes
of a Hi-Seq 2000.
Raw reads for all libraries are available for download
from NCBI using the following link: [48].
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Abundance profile (AP)
When provided with sample data, EDDA uses the entity
count and the sample abundance profile from the data
(when multiple samples are provided, the counts are ag-
gregated to get an average frequency profile) to do si-
mulations. Users can also explicitly provide a profile or
choose from among pre-defined profiles including BP
(for BaySeq Profile; the profile used in simulations by
Hardcastle et al. [15]), HBR (a profile derived from a
‘human brain reference’ dataset [49]) and the profile
from Wu et al. [35]. In order to simulate with entity
counts that differ from the original profile, EDDA allows
users to sample entities (without replacement for sub-
sampling and with replacement for over-sampling) from
the middle 80% (entities are ordered by relative abun-
dance), top 10%, and bottom 10% independently. This
procedure is designed to maintain the dynamic range of
the original profile. In addition, to avoid working with
entities with very low counts, EDDA allows users to fil-
ter out those with counts below a minimum threshold
for all replicates (default of 10).Perturbation profile
If EDDA is provided with sample data under two con-
ditions then the profile of differential abundance seen
there is assigned to genes by keeping the relationship of
mean expression and fold change. Specifically, EDDA
applies a DAT (DESeq and FDR cutoff of 5% by default,
after mode normalization) to the sample data to identify
differentially abundant entities and their corresponding
fold-changes (f i ¼ x2i =x1i where x1i and x2i are the mean
relative abundance of entity i under the first and second
condition, respectively). Given d differentially abundant
entities, with fold-changes f1 to fd, a set of d entities
from the first condition are perturbed by these fold-
changes to obtain the abundance profile for the second
condition (that is, x2i ¼ √f j  x1i and x1i ¼ x1i =√f j ) while
retaining the correspondence between mean expression
level and fold-change. In addition, to account for un-
detected entities an additional fraction of entities is ran-
domly selected (from those that fail the FDR cutoff and
with fold-change >1.5) and their observed fold-changes
used to perturb abundance profiles as before. The frac-
tion of entities was determined to ensure that the overall
count matched the expected number of differentially
abundant entities in the dataset (estimated from the ex-
pected number of true positives at each gene’s FDR level).
In the absence of sample data, EDDA also allows users to
specifically set the percentage of entities with increased
and decreased entity counts (PDA), ranges for the fold-
changes (FC) and the distribution to sample fold-changes
from (for example, Log-normal, Normal, or Uniform).Simulation model (SM)
The default model for simulations in EDDA is the Full
model where the mean abundance for each entity (under
each condition) and the dispersion value provided (SV)
is used to compute means for the replicates using a
Negative Binomial distribution (this is done emulating
the procedure in baySeq [15] where each entity has a
dispersion sampled from a gamma distribution). When
sample data are available, EDDA estimates dispersion
values by using the procedure in DESeq (alternately,
edgeR) to fit the empirical distribution. Entity abundan-
ces for each replicate are then normalized to get a fre-
quency vector (that sums to 1) to simulate count data
from a Multinomial distribution (where the total count
is sampled from Uniform(0.9 ×ND, 1.1 ×ND) and ND is
the number of data-points specified by the user). EDDA
also allows users a simpler Negative Binomial model
(NB) where the counts are directly obtained from the
Negative Binomial sampling described above and a
Multinomial model where the abundance profile (nor-
malized to 1) is used to directly simulate from the Multi-
nomial distribution. EDDA also supports an outlier
simulation model (turned off by default) as these are fre-
quently encountered in real applications (for example, in
RNA-seq data [28]). Specifically, to generate outlier data-
points as in Love et al. [28], a random subset of genes
(upto x% as specified by the user; default 15%) is selected
and counts for them scaled up or down in a randomly
chosen sample, by a user-specified factor (100 by default).
In addition, the presence of outliers in sample data can
allow users to simulate more realistic datasets using the
Model-Free aproach as detailed below.
Model-free approach
The Model-Free approach is based on a sub-sampling
strategy and, therefore, requires sample data (ideally with
many replicates and data-points) from which to generate
the simulated counts. For RNA-seq, single-cell RNA-seq,
and Metagenomic simulations, EDDA is packaged with
sample datasets discussed in this study. If enough repli-
cates are available in the sample dataset (that is, greater
than NR × desired number of simulations), EDDA sub-
samples counts from the entity in the sample dataset
with the closest average count to the intended simulated
abundance level (scaling counts as needed). To simulate
more replicates than the number available in sample data,
EDDA groups entities according to their average count to
sub-sample entity counts. This approach was validated
using RNA-seq data [35] where more than 90% of genes
had similar expression variability compared to the 10
closest genes (in terms of average count; Kolmogorov-
Smirnov test P value <0.05), as opposed to 2% of genes
in the case of random groupings. After simulating vari-
ability in counts across replicates using the model-free
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vert counts back to a relative abundance profile for
multinomial sampling of counts with a desired number
of data-points.
Mode normalization
In principle, the ideal normalization factor for detecting
differential abundance would be based on counts for an
entity that is not differentially abundant (or the sum of
counts for all such entities, see Figure 5). The idea be-
hind mode-normalization is to identify such entities
under the assumption that non-differentially-abundant
entities will tend to have similar un-normalized fold
changes (UFCs, computed as ratio of average counts
across conditions). In methods such as DESeq, a related
idea is implemented using a quantity called the size-
factor (= ratio of observed count to a pseudo-reference
sample computed by taking the geometric mean across
samples) and by taking the median (or upper-quartile)
size factor under the assumption that it would typically
come from a non-differentially-abundant entity.
Mode normalization in EDDA is based on calculating
UFCs for all entities and determining the approximate
modes for their empirical distribution (Additional file 1:
Figure S10). Specifically, we used a kernel density esti-
mation approach [50] to smooth the empirical distribu-
tion and to compute local maxima for it. In cases where
the number of maxima is not as expected (that is, 3, cor-
responding to entities with decreased, unchanged and
increased relative abundance), the bandwidth for smoo-
thing was decreased as needed (starting from 0.5, in
steps of 0.02, till the number of maxima is as close to 3
as possible). If the final smoothed distribution was uni-
or tri-modal then the mode in the middle (presumably
composed of non-differentially-abundant entities) was
chosen and the normalization factor was calculated from
the geometric mean of 10 entity counts around the
mode. For bimodal distributions, selecting the correct
mode is potentially error-prone and we flag this to the
user, picking the mode with the narrowest peak (as given
by the width of the peak at half the maximum value)
and calculating the normalization factor as before.
Parameter/DAT settings and EDDA extensions
EDDA is designed to be a general-purpose experimental
design tool (that is easily extendable due to its implemen-
tation in R) and correspondingly it provides significant
flexibility in user settings. In addition, we investigated the
question of which parameter values are typically seen in
common applications (for example, RNA-seq, Nanostring
analysis and Metagenomics) and used these to guide the
evaluations presented in this study as detailed below.
For RNA-seq experiments, ECs in the range 1,000 (mi-
crobial genomes) to 30,000 (mammalian genomes) arecommon with NR and ND in the range (1, 10) and (10,
10,000) per entity, respectively. For Nanostring and
Metagenomic experiments (species profile), EC can be
significantly lower (in the range (10, 1,000)) as well as
significantly higher (>1 million for Metagenomic gene
profile). For the RNA-seq datasets analyzed in this study,
SV was found to be in the range (0.1, 0.9) (Additional
file 1: Table S1) though much higher variability was seen
in Metagenomic data (>5). Abundance profiles are best
learnt from pilot data but in their absence, the sample
profiles provided with EDDA should serve as a useful
range of proxies. For RNA-seq experiments, PDA values
in the range (5%, 30%) can be expected while Nanostring
and Metagenomic experiments can have even higher
percentages. Fold change distributions were typically ob-
served to be well-approximated by a Log-normal model
(Log-normal(μ, σ)) but other models are also feasible in
EDDA (for example, Normal(μ, σ) and Uniform(a, b)).
For DATs such as DESeq, edgeR, baySeq, NOISeq, and
Metastats that are implemented in R, EDDA is set to call
corresponding R functions, running them with default
parameters and normalization options unless otherwise
specified. The results in this study were obtained with
the following versions of the various packages: DESeq
(v1.7.6), edgeR (v2.4.6), baySeq (v1.8.3), NOISeq (version
as of 20 April 2011), Metastats (version as of 14 April
2009), and R (v2.14.0). For Cuffdiff, the relevant C++
code was extracted from Cufflinks (v2.1.1) and incorpo-
rated into EDDA as a pre-compiled dynamically-linked
library using Rcpp [45,51].
In its current form, EDDA installs the DATs listed in
Table 2 by default. In addition, EDDA is designed to
support the easy integration of new DATs and a step-by-
step guide to do so (with the Wilcoxon test used here
as an example) is provided as part of the package (see
Additional file 2: Text). EDDA is also designed to be
extendable in terms of simulation models and a guide
for this is also provided in the installation package (see
Additional file 2: Text).
EDDA modules
For expert users the full functionality of EDDA and
mode normalization is available in a package written in
the statistical computing language R that can be freely
downloaded from public websites such as SourceForge
and Bioconductor. In addition, to enable easy access for
those who are unfamiliar with the R environment, we
designed web-based modules that encapsulate typical
use cases for EDDA [25] (also see Figure 1a) including
modules for:
a) Differential Abundance Testing: This module is
meant to enable users to easily run a panel of DATs
on any given dataset, to assess the variability of
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union of these results, and correspondingly select a
more robust or comprehensive set of calls for
downstream analysis. The assumption here is that a
user has already generated all their data and would
like a limited comparison of results from various
DATs.
b) Performance Evaluation: The purpose of this module
is to allow users to evaluate the relative performance
of various DATs based on the characteristics of their
experimental setting. A salient feature of this
module is that users can adjust the stringency
thresholds for the DATs and immediately assess the
impact on performance, without re-running the
DATs. The expected use case for this module is
when users have pilot data and would like to do a
systematic evaluation of the DATs.
c) Experimental Design: This module allows users to
specify desired performance targets and the range of
experimental choices that are feasible, to identify
combinations that can meet the targets as well as
the appropriate DATs that can be used to achieve
them. Ideally, users in the planning stages of an
experiment would use this module to optimize their
experimental design.
Note that the experimental design module is arguably
the most sophisticated and valuable among the three
modules and encapsulates the main intended function
for EDDA.
Preprocessing of RNA-seq datasets
Count data for RNA-seq datasets in ENCODE (for
GM12892 NR =3, MCF7 NR =3, and h1-hESC NR =4)
were obtained directly from [52]. Count data for Pickrell
et al. [53] (NR =69) were obtained from [54]. Reads
from each library of the K562 single cell RNA-seq data-
set were mapped uniquely and independently using
TopHat [55] (version 2.0.7) against the human reference
genome (hg19). Raw counts for each gene were then
extracted using Human Gencode 19 annotations and
htseq-count [56].
Single-cell RNA-seq and metagenomic analysis
RNA-seq count data from single-cell experiments in
Ramskold et al. [41] were obtained from Additional file 1:
Table S4 in the manuscript (15,000 genes and 10 sam-
ples – six putative circulating tumor cells and four from
the melanoma cell line SKMEL5; RPKM values were
converted back to raw counts). Metagenomic count data
from the study by Qin et al. [42] were obtained from
[57] (1.14 million genes and 145 samples). The fit of the
metagenomic count data to the Negative Binomial dis-
tribution was assessed using a Kolmogorov-Smirnovtest, where <0.1% of the genes failed the test at a P value
threshold of 0.01. Characteristics of both datasets were
learned by EDDA and used to generate simulated data-
sets (Model-Free for single-cell and with the Full Model
for metagenomic data).
To build a predictive model for type 2 diabetes from
the data in Qin et al. [42], we followed the procedure
described there to identify 50 marker genes from the top
1,000 differentially abundant genes (based on edgeR P
values) by employing the maximum relevance minimum
redundancy (mRMR) feature selection framework [58].
The identified marker genes were combined into a ‘T2D
index’ (= mean abundance of positive markers - mean
abundance of negative markers) for each sample, which
was then used to rank samples and compute ROC
curves as in the original study.Nanostring analysis
Nanostring count data were obtained from an in-house
preliminary study of prognostic and predictive gene sig-
natures for breast cancer (manuscript in preparation).
Briefly, expression levels of 107 genes of interest from
369 patients in different stages of breast cancer and with
known estrogen receptor (ER) alpha status and clinical
outcomes were quantified using the NanoString nCoun-
ter System (NanoString, WA, USA). The raw data were
normalized by different generally applicable methods
(for example, median normalization as implemented in
DESeq, mode normalization from the EDDA package,
and UQN as implemented in edgeR; see Table 2) as well
as the recommended standard from the NanoString data
analysis guide (normalized by positive and negative con-
trols, followed by global normalization). Note that as this
dataset has multiple categories we extended the standard
two-condition version of mode-normalization by ran-
domly labelling samples as controls or cases to identify
the top 10 genes that are consistently chosen. In order
to measure the impact of normalization on the ability to
separate patients based on their ER status a standard F-
score was calculated, as the ratio of between-group vari-
ance to within-group variance of mean counts for the
eight ER signature genes (formally F‐score = FBetween/
FWithin, where FBetween = |X1|(E(X1) - E(X))
2 + |X2|(E(X2) -
E(X))2 and FWithin = (|X1|Var(X1) + |X2|Var(X2))/(|X1| + |
X2| - 2) and X = X1 ∪ X2, for mean counts X1 and X2 in
the two groups).Availability
As an open-source R package at https://sourceforge.
net/projects/eddanorm/ or http://www.bioconductor.org/
packages/devel/bioc/html/EDDA.html and as web-modules
at http://edda.gis.a-star.edu.sg.
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